Molecular tumor profiling is becoming a routine part of clinical cancer care, typically involving tumor-only panel testing without matched germline. We hypothesized that integrated germline sequencing ...
Among patients with RCC, unselected for a known familial predisposition, 13.4% had P/LP variants. Almost half of patients with P/LP variants had a potentially targetable mutation. Targeted gene panel ...
Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine. Some leading organizations in the field of cell and gene therapies recently issued a call for a 10-year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results